Pharmacie du Bien-être SRL
Pharmacie du Bien-être reported total assets of 190,415 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026).
The score of Pharmacie du Bien-être shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +43 % Total assets +30 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmacie du Bien-être's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 24 Jun 2025
- Year ended 31 Dec 2023filed on 01 Jul 2024
- Year ended 31 Dec 2022filed on 23 Aug 2023
- Year ended 31 Dec 2021filed on 16 Jun 2022
Pharmacie du Bien-être's financial analysis
- Solvency51.5%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmacie du Bien-être
Pharmacie du Bien-être's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0727.381.323
- VAT number
- BE0727381323
- Peppol
- Registered · 0208:0727381323 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 May 2019
- Registered office
- 1020 Brussels
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmacie du Bien-être (SRL) has been based in Brussels since 2019, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 7,726 € and equity of 98,090 €; its revenue is not published. Its solvency stands at 51.5%, above the median of its sector (37.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmacie du Bien-être
Companies in the same business, of comparable size and area, outside its group.
- Bopre Retail sale of pharmaceutical products Aalst · balance sheet 196,068 €
- Apotheek Synaps Park Retail sale of pharmaceutical products Genk · balance sheet 189,539 €
- Panadem Retail sale of pharmaceutical products Woluwe-Saint-Pierre · balance sheet 188,078 €
- Heyde Pharma Retail sale of pharmaceutical products Jabbeke · balance sheet 192,810 €
- Medisame Retail sale of pharmaceutical products Stabroek · balance sheet 184,789 €
- Paracelsus Pharma Projects Retail sale of pharmaceutical products Aalter · balance sheet 197,179 €
- Pharmed Retail sale of pharmaceutical products Schaerbeek · balance sheet 183,800 €
- Emilie Retail sale of pharmaceutical products Schaerbeek · balance sheet 183,476 €
Frequently asked questions about Pharmacie du Bien-être
What is the revenue of Pharmacie du Bien-être?
Pharmacie du Bien-être files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmacie du Bien-être?
In Belgium, the VAT number is the company number prefixed with BE: BE0727381323 for Pharmacie du Bien-être, if the company is VAT-registered. Its company number (CBE) is 0727.381.323.
Where is the registered office of Pharmacie du Bien-être?
According to the CBE register, the registered office of Pharmacie du Bien-être is in 1020 Brussels.
What is the equity of Pharmacie du Bien-être?
At the close of the 2025 financial year, the equity of Pharmacie du Bien-être amounts to 98,090 €, a solvency of 51.5% of total assets.
Who manages Pharmacie du Bien-être?
The register lists 1 active mandates at Pharmacie du Bien-être. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmacie du Bien-être
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →